Healthcare Services

Global Acute Pharyngitis Market Forecast Highlighting Expansion And Competitive Dynamics

May 27, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Larger Will The Acute Pharyngitis Market Become By 2030 Compared To 2026?

The acute pharyngitis market has demonstrated significant expansion in recent years. Projections indicate it will grow from $2.89 billion in 2025 to $3.13 billion in 2026, with a compound annual growth rate (CAGR) of 8.2%. Historically, this growth has been primarily driven by the high prevalence of viral and bacterial pharyngitis, limited awareness regarding available treatments, the expansion of healthcare infrastructure, an increase in outpatient visits, and the growing accessibility of pharmaceutical options.

The market for acute pharyngitis is projected to experience substantial growth over the coming years. It is anticipated to reach a valuation of $4.25 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.0%. This expansion during the forecast period is driven by factors such as the development of innovative antivirals and antibiotics, increasing integration of telemedicine, the proliferation of online pharmacy platforms, heightened awareness of herbal and alternative treatments, and the expansion of homecare and specialized care services. Key trends expected within the forecast timeframe include the increasing application of antibiotics and antivirals specifically for acute pharyngitis, a rise in the uptake of over-the-counter medications, a growing inclination towards herbal and alternative remedies, the broadening of hospital and homecare treatment choices, and an emphasis on anti-inflammatory and corticosteroid therapeutic approaches.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21082&type=smp

Which Major Factors Are Contributing To The Development Of The Acute Pharyngitis Market?

The increasing occurrence of influenza is anticipated to boost the acute pharyngitis market’s expansion moving forward. Influenza results from infection with influenza viruses, which disseminate via respiratory droplets from coughs, sneezes, or contact with contaminated surfaces. The rising prevalence of influenza is influenced by factors such as seasonal shifts, low vaccination uptake, increased human mobility, viral mutations, and compromised immunity in specific populations. Acute pharyngitis treatment assists influenza patients by alleviating throat inflammation and pain, reducing swallowing discomfort, preventing secondary bacterial infections, and supporting overall recovery. This approach, when combined with antiviral medications, adequate hydration, and rest, improves the body’s capacity to combat the influenza virus more effectively. For instance, according to the Centers for Disease Control and Prevention, a US-based government agency, as of February 2025, the percentage of clinical lab tests that were positive for influenza reached 31.6%, an increase from 29.4% the previous week and 18.6% at the start of the year. Therefore, the escalating prevalence of influenza is propelling the growth of the acute pharyngitis market.

Which Segment Groups Define The Acute Pharyngitis Market Landscape?

The acute pharyngitis market covered in this report is segmented –

1) By Treatment: Antibiotics, Antivirals, Over-the-Counter (OTC) Medications, Corticosteroids And Anti-inflammatory Drugs

2) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

3) By End-User: Hospitals, Homecare, Speciality Centres, Other End Users

Subsegments:

1) By Antibiotics: Penicillins, Cephalosporins, Macrolides

2) By Antivirals: Neuraminidase Inhibitors, Nucleoside Analogs

3) By Over-the-Counter (OTC) Medications: Analgesics, Throat Lozenges, Cough Syrups

4) By Corticosteroids And Anti-inflammatory Drugs: Glucocorticoids, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

What Trends Are Influencing The Future Of The Acute Pharyngitis Market?

Leading companies in the acute pharyngitis market are concentrating on developing advanced solutions, such as multiplex syndromic Point-of-Care (POC) testing, to improve diagnostic speed, enhance accuracy, and support pathogen-specific treatment decisions. Multiplex POC testing is a technological approach capable of detecting multiple pathogens from a single sample rapidly, which allows clinicians to differentiate between viral and bacterial infections and reduce unnecessary antibiotic use. For example, in June 2024, bioMérieux, a France-based medical equipment manufacturer, obtained FDA Special 510(k) clearance and a CLIA waiver for its BIOFIRE SPOTFIRE Respiratory/Sore Throat Panel Mini. This panel identifies common viral causes of sore throat and Group A Streptococcus from a single throat or nasopharyngeal swab in approximately 15 minutes. Operating on the BIOFIRE SPOTFIRE platform, the test enables clinicians to select either a small or larger multiplex respiratory panel according to their needs and setting. The Mini panel shows strong sensitivity for four respiratory viruses, including rhinovirus and influenza, and for Streptococcus A, thereby assisting clinicians in making rapid, targeted treatment decisions.

Who Are The Major Companies Operating In The Acute Pharyngitis Market?

Major companies operating in the acute pharyngitis market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, F. Hoffmann La Roche AG, Abbott Laboratories, Bayer AG, Eli Lilly and Company, Bristol Myers Squibb Company, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Sandoz Group AG, Hikma Pharmaceuticals PLC, Lupin Limited, Alkem Laboratories Ltd., Cipla Limited, Sun Pharmaceutical Industries Limited

Access The Complete Acute Pharyngitis Market Report:

https://www.thebusinessresearchcompany.com/report/acute-pharyngitis-global-market-report

What Is The Largest Regional Market In The Acute Pharyngitis Market?

North America was the largest region in the acute pharyngitis market in 2025. The regions covered in the acute pharyngitis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Acute Pharyngitis Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=21082&type=smp

Browse Through More Reports Similar to the Global Acute Pharyngitis Market 2026, By The Business Research Company

Severe Acute Respiratory Syndrome Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/severe-acute-respiratory-syndrome-treatment-global-market-report

Esophageal Dysphagia Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/esophageal-dysphagia-global-market-report

Acute Bacterial Skin And Skin Structure Infections Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/acute-bacterial-skin-and-skin-structure-infections-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795